InMed Pharmaceuticals Inc. — Investor Relations & Filings
Filings indexed
461
across all filing types
Latest filing
2026-04-03
Regulatory Filings
Country
CA
Canada
Listing
US
INM
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company developing a pipeline of proprietary small molecule drug candidates that target the CB1 and CB2 cannabinoid receptors. The company's therapeutic pipeline includes preclinical programs for Alzheimer's disease (INM-901) and dry age-related macular degeneration (INM-089). In dermatology, InMed has completed a Phase 2 clinical trial for the treatment of epidermolysis bullosa. Additionally, its subsidiary, BayMedica, manufactures and supplies high-purity, rare cannabinoids such as cannabichromene (CBC), tetrahydrocannabivarin (d9-THCV), and cannabidivarin (CBDV) as raw ingredients for the business-to-business health and wellness market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | |
| 424B5 - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | |
| 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-03-23 | English | |
| S-3 - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-03-20 | English | |
| 8-K - INMED PHARMACEUTICALS INC. (0001728328) (Filer) | 2026-02-12 | English | |
| 10-Q Filing | 2026-02-11 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
7 filings
| |||||
| 33301130 | 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | ||
| 33301119 | 424B5 - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-04-03 | English | ||
| 33012916 | 8-K - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-03-23 | English | ||
| 33002557 | S-3 - InMed Pharmaceuticals Inc. (0001728328) (Filer) | 2026-03-20 | English | ||
| 32897365 | 8-K - INMED PHARMACEUTICALS INC. (0001728328) (Filer) | 2026-02-12 | English | ||
| 31504961 | 10-Q Filing | 2026-02-11 | English | ||
| 31504697 | SCHEDULE 13G Filing | 2026-01-20 | English | ||
|
2025
8 filings
| |||||
| 13089323 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089322 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089324 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089325 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089326 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089327 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089328 | Director's Dealing 2025 | 2025-12-19 | English | ||
| 13089329 | Director's Dealing 2025 | 2025-12-19 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
InMed Pharmaceuticals Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35386/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35386 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35386 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35386 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35386}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for InMed Pharmaceuticals Inc. (id: 35386)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.